World Courier targets Chinese pharmaceutical shipments
World Courier World Courier, the US-based international courier network, is targeting the booming Chinese pharmaceutical sector by extending its cold chain network to 36 major cities in the country, including provincial capitals.
“China is poised to become the fourth largest pharmaceutical market by 2012,” said Henning Voss, director for World Courier North Asia. But he noted: “China presents many infrastructure challenges for temperature-controlled and clinical trial shipments. Domestic transport companies do not yet fully understand the many international standards at play in handling these types of shipments. As such, the real concerns and requirements of major pharmaceutical clients in China have not been adequately addressed until now.”
With its new operational network, World Courier could help pharmaceutical companies, central labs and clinical research organizations improve their supply chain efficiencies, Voss said. All temperature-sensitive pharmaceutical and clinical trial shipments are handled by trained personnel according to established operating practices and IATA transportation standards. Only validated packaging complete with industry-accepted cold-pack mediums and temperature recording devices are used.
